Celldex Therapeutics reported $5.82M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Agenus AGEN:US $ 21.38M 4.73M
Amgen AMGN:US $ 1.31B 79M
Applied Genetic Technologies AGTC:US $ 3.68M 207K
Aptinyx Inc APTX:US $ 4.93M 142K
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Biocept BIOC:US $ 5.37M 177.24K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Cytrx CYTR:US 1.53M 354.61K
Glaxosmithkline GSK:US 2.5B 6M
Immunogen IMGN:US $ 10.3M 569K
Merrimack Pharmaceuticals MACK:US $ 886K 21K
Nektar Therapeutics NKTR:US $ 29.47M 87K
Newlink Genetics NLNK:US 3.38M 1.18M
Northwest Biotherapeutics NWBO:US 6.65M 721K
Pfizer PFE:US $ 2.73B 61M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Seattle Genetics SGEN:US $ 180.28M 15.15M